Evidence map›Paper›PMID 42786159›Full record

ArticleNature communications2026

Copper-catalyzed enantioselective allylation of cyclic anhydrides for generation of multiple chiral centers.

Zhengshuai Xu, Yuan Yuan, Zhen Liu, Xue Zhang, Hui Qian, Shengming Ma

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Zhengshuai Xu *Research Center for Molecular Recognition and Synthesis, Department of Chemistry, Fudan University, Shanghai, PR China.
Yuan Yuan *Research Center for Molecular Recognition and Synthesis, Department of Chemistry, Fudan University, Shanghai, PR China.
Zhen LiuState Key Laboratory of Organometallic Chemistry, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, Shanghai, PR China.
Xue ZhangState Key Laboratory of Organometallic Chemistry, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, Shanghai, PR China. xzhang@sioc.ac.cn.ORCID http://orcid.org/0000-0001-7995-9879
Hui QianResearch Center for Molecular Recognition and Synthesis, Department of Chemistry, Fudan University, Shanghai, PR China. qian_hui@fudan.edu.cn.ORCID http://orcid.org/0000-0002-5606-9213
Shengming MaResearch Center for Molecular Recognition and Synthesis, Department of Chemistry, Fudan University, Shanghai, PR China. masm@sioc.ac.cn.ORCID http://orcid.org/0000-0002-2866-2431

Funding

National Natural Science Foundation of China (National Science Foundation of China) 21988101, 22171048
6 · The paper itself

Abstract

Chirality wildly exists in natural products and pharmaceuticals. The efficient construction of multiple chiral centers in a single catalytic step is challenging due to the issues of both enantioselectivity and diastereoselectivity. Herein, a catalytic protocol for simultaneous generation of multiple chiral centers is developed: a stereodivergent reaction of non-symmetric cyclic anhydrides with 1,1-disubstituted allenes affords the products with either 1,3- or 1,4-two chiral centers, which is governed by the absolute configurations of the chiral centers in the enantiomeric ligands of (R,R)-Ph-BPE or (S,S)-Ph-BPE, respectively; the Cu-catalyzed enantioselective allylative desymmetrization of meso bicyclic anhydrides with 1,1-disubstituted allenes generates chiral γ-keto carboxylic acids bearing three stereocenters. Such a protocol is successfully demonstrated for its application to prepare compounds containing four to five stereocenters. Density functional theory studies reveal that the allylation proceeds through a six-membered transition state, where the ligand-substrate steric interactions govern the observed regio-, enantio-, and diastereoselectivity.

Identifiers

PMID42786159
PMCPMC13612400

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.